HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Teklu Legesse Selected Research

Teklu Legesse Research Topics

Disease

5Neoplasms (Cancer)
12/2022 - 01/2018
2Glioblastoma (Glioblastoma Multiforme)
06/2018 - 01/2018
2Brain Neoplasms (Brain Tumor)
06/2018 - 01/2018
1Prostatic Neoplasms (Prostate Cancer)
12/2022
1Peritonitis
05/2022
1Mesothelioma
05/2022
1Serositis
05/2022
1Hyperplasia
05/2022
1Gastritis
02/2022
1Cytomegalovirus Infections (Inclusion Disease)
02/2022
1Leiomyoma (Uterine Fibroids)
10/2019
1Smooth Muscle Tumor
10/2019
1Leiomyosarcoma
10/2019
1Sarcoma (Soft Tissue Sarcoma)
10/2019
1Leiomyomatosis
10/2019
1Glioma (Gliomas)
06/2018
1Gliosarcoma
01/2018

Drug/Important Bio-Agent (IBA)

2NivolumabIBA
05/2022 - 02/2022
2Messenger RNA (mRNA)IBA
06/2018 - 01/2018
2Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
06/2018 - 01/2018
2Proteins (Proteins, Gene)FDA Link
06/2018 - 01/2018
1Prostate-Specific Antigen (Semenogelase)IBA
12/2022
1Immune Checkpoint InhibitorsIBA
02/2022
1SteroidsIBA
02/2022
1Taxoids (Taxanes)IBA
10/2019
1Docetaxel (Taxotere)FDA Link
10/2019
1TubulinIBA
10/2019
1Dinoprostone (PGE2)FDA Link
10/2019
1Excipients (Suspending Agents)IBA
10/2019
1GemcitabineFDA Link
10/2019
1taxaneIBA
10/2019
1Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
06/2018
1EnzymesIBA
06/2018
1DNA (Deoxyribonucleic Acid)IBA
06/2018
1DecitabineFDA Link
06/2018
1TWEAK ReceptorIBA
06/2018
1AGI-5198IBA
06/2018
1Temozolomide (Temodar)FDA LinkGeneric
01/2018

Therapy/Procedure

3Therapeutics
05/2022 - 01/2018
1Aftercare (After-Treatment)
12/2022
1Prostatectomy (Retropubic Prostatectomy)
12/2022
1Immunotherapy
05/2022
1Drug Therapy (Chemotherapy)
01/2018